semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42294355
Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.
Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.
- 저자
- Franziska S Ulrich, Morten Frost Nielsen, Nicola Napoli, Andrea M Burden
- 저널
- The Lancet regional health. Europe
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1016/j.lanepe.2026.101738
문헌 요약
The SUSTAIN-7 trial demonstrated greater HbA1c and bodyweight reductions with once-weekly semaglutide versus dulaglutide in type 2 diabetes, but strict eligibility criteria limit external validity. We evaluated the comparative real-world effectiveness and safety of these agents in UK primary care. Using the IQVIA Medical Research Data (IMRD) incorporating…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.